These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. 2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling. Budzik B; Garzya V; Shi D; Walker G; Lauchart Y; Lucas AJ; Rivero RA; Langmead CJ; Watson J; Wu Z; Forbes IT; Jin J Bioorg Med Chem Lett; 2010 Jun; 20(12):3545-9. PubMed ID: 20483599 [TBL] [Abstract][Full Text] [Related]
24. Discovery of biaryl anthranilides as full agonists for the high affinity niacin receptor. Shen HC; Ding FX; Luell S; Forrest MJ; Carballo-Jane E; Wu KK; Wu TJ; Cheng K; Wilsie LC; Krsmanovic ML; Taggart AK; Ren N; Cai TQ; Deng Q; Chen Q; Wang J; Wolff MS; Tong X; Holt TG; Waters MG; Hammond ML; Tata JR; Colletti SL J Med Chem; 2007 Dec; 50(25):6303-6. PubMed ID: 17994679 [TBL] [Abstract][Full Text] [Related]
25. Discovery of the imidazole-derived GPR40 agonist AM-3189. Ma Z; Lin DC; Sharma R; Liu J; Zhu L; Li AR; Kohn T; Wang Y; Liu JJ; Bartberger MD; Medina JC; Zhuang R; Li F; Zhang J; Luo J; Wong S; Tonn GR; Houze JB Bioorg Med Chem Lett; 2016 Jan; 26(1):15-20. PubMed ID: 26620255 [TBL] [Abstract][Full Text] [Related]
26. Discovery of pyrimidine carboxamides as potent and selective CCK1 receptor agonists. Wang L; Hubert JA; Lee SJ; Pan J; Qian S; Reitman ML; Strack AM; Weingarth DT; MacNeil DJ; Weber AE; Edmondson SD Bioorg Med Chem Lett; 2011 May; 21(10):2911-5. PubMed ID: 21493064 [TBL] [Abstract][Full Text] [Related]
27. Discovery and optimization of a novel series of GPR142 agonists for the treatment of type 2 diabetes mellitus. Lizarzaburu M; Turcotte S; Du X; Duquette J; Fu A; Houze J; Li L; Liu J; Murakoshi M; Oda K; Okuyama R; Nara F; Reagan J; Yu M; Medina JC Bioorg Med Chem Lett; 2012 Sep; 22(18):5942-7. PubMed ID: 22884988 [TBL] [Abstract][Full Text] [Related]
28. Alkyl-substituted amino acid amides and analogous di- and triamines: new non-peptide G protein activators. Leschke C; Storm R; Breitweg-Lehmann E; Exner T; Nürnberg B; Schunack W J Med Chem; 1997 Sep; 40(19):3130-9. PubMed ID: 9301677 [TBL] [Abstract][Full Text] [Related]
29. Discovery of hydroxyaniline amides as selective Extracellular Regulated Kinase (Erk) inhibitors. Zhu HY; Desai J; Deng Y; Cooper A; Wang J; Shipps J; Samatar A; Carr D; Windsor W Bioorg Med Chem Lett; 2015 Apr; 25(7):1627-9. PubMed ID: 25716905 [TBL] [Abstract][Full Text] [Related]
30. Design, Synthesis, and Structure-Activity Relationship Studies of (4-Alkoxyphenyl)glycinamides and Bioisosteric 1,3,4-Oxadiazoles as GPR88 Agonists. Rahman MT; Decker AM; Langston TL; Mathews KM; Laudermilk L; Maitra R; Ma W; Darcq E; Kieffer BL; Jin C J Med Chem; 2020 Dec; 63(23):14989-15012. PubMed ID: 33205975 [TBL] [Abstract][Full Text] [Related]
31. Discovery of novel orally bioavailable GPR40 agonists. Lu H; Fei H; Yang F; Zheng S; Hu Q; Zhang L; Yuan J; Feng J; Sun P; Dong Q Bioorg Med Chem Lett; 2013 May; 23(10):2920-4. PubMed ID: 23582779 [TBL] [Abstract][Full Text] [Related]
32. 2' biaryl amides as novel and subtype selective M1 agonists. Part I: Identification, synthesis, and initial SAR. Budzik B; Garzya V; Shi D; Foley JJ; Rivero RA; Langmead CJ; Watson J; Wu Z; Forbes IT; Jin J Bioorg Med Chem Lett; 2010 Jun; 20(12):3540-4. PubMed ID: 20483611 [TBL] [Abstract][Full Text] [Related]
33. Switching Lysophosphatidylserine G Protein-Coupled Receptor Agonists to Antagonists by Acylation of the Hydrophilic Serine Amine. Sayama M; Uwamizu A; Ikubo M; Chen L; Yan G; Otani Y; Inoue A; Aoki J; Ohwada T J Med Chem; 2021 Jul; 64(14):10059-10101. PubMed ID: 34233115 [TBL] [Abstract][Full Text] [Related]
34. Discovery and evaluation of a novel monocyclic series of CXCR2 antagonists. Austin RP; Bennion C; Bonnert RV; Cheema L; Cook AR; Cox RJ; Ebden MR; Gaw A; Grime K; Meghani P; Nicholls D; Phillips C; Smith N; Steele J; Stonehouse JP Bioorg Med Chem Lett; 2015 Apr; 25(7):1616-20. PubMed ID: 25708618 [TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationship study on small peptidic GPR54 agonists. Tomita K; Niida A; Oishi S; Ohno H; Cluzeau J; Navenot JM; Wang ZX; Peiper SC; Fujii N Bioorg Med Chem; 2006 Nov; 14(22):7595-603. PubMed ID: 16879969 [TBL] [Abstract][Full Text] [Related]
37. Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors. Wang Y; Cai W; Zhang G; Yang T; Liu Q; Cheng Y; Zhou L; Ma Y; Cheng Z; Lu S; Zhao YG; Zhang W; Xiang Z; Wang S; Yang L; Wu Q; Orband-Miller LA; Xu Y; Zhang J; Gao R; Huxdorf M; Xiang JN; Zhong Z; Elliott JD; Leung S; Lin X Bioorg Med Chem; 2014 Jan; 22(2):692-702. PubMed ID: 24388993 [TBL] [Abstract][Full Text] [Related]
38. Carbazole-containing amides and ureas: Discovery of cryptochrome modulators as antihyperglycemic agents. Humphries PS; Bersot R; Kincaid J; Mabery E; McCluskie K; Park T; Renner T; Riegler E; Steinfeld T; Turtle ED; Wei ZL; Willis E Bioorg Med Chem Lett; 2018 Feb; 28(3):293-297. PubMed ID: 29292223 [TBL] [Abstract][Full Text] [Related]
39. Discovery and optimization of N-(3-(1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-4-yloxy)phenyl)benzenesulfonamides as novel GPR119 agonists. Yu M; Ken Zhang J; Wang Y; Zhu J; Kayser F; Medina JC; Siegler K; Conn M; Shan B; Grillo MP; Coward P; Jim Liu J Bioorg Med Chem Lett; 2014 Jan; 24(1):156-60. PubMed ID: 24332491 [TBL] [Abstract][Full Text] [Related]
40. Discovery of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines as potent PIM inhibitors. Wu B; Wang HL; Cee VJ; Lanman BA; Nixey T; Pettus L; Reed AB; Wurz RP; Guerrero N; Sastri C; Winston J; Lipford JR; Lee MR; Mohr C; Andrews KL; Tasker AS Bioorg Med Chem Lett; 2015 Feb; 25(4):775-80. PubMed ID: 25616902 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]